Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by tuesdaynightridon Sep 29, 2015 12:15pm
190 Views
Post# 24145286

Theralase Financials

Theralase Financials
No reason to visit here vey often. Much of the same old crowd repeats the same old nonsense. It has become a sin on this board to actually quote what Mr.White has historically promised. That is still called bashing.... the same as it was in 2014.

Tomorrow is the end of the 3rd quarter and the long awaited approval of the TLC-2000 device to get some revenue started is still not approved. Of course, HC gets all the blame and I won't even bring up his pronouncement of ph1/2b trials with FDA and HC by end of 4th quarter 2014.

In 2014, Mr. White projected TLC-2000 sales to be $5 million for 2015 and $10 million for 2016 (300+ units sold in 2015 and 600+ in 2016 as I recall). Where is that revenue? It was always needed to fund the cancer side!

Here's the open secret... 20 days from now, you will get the financials for the 3rd quarter.
Mr. White has stated the cash balance to be C$6 million 2 weeks ago but my guess is that this balance will be closer to C$5 million at quarter close. My experience with him is that he will have a good excuse. That the final CiTox bill was due end of Sept, etc, etc. Beyond that, when you actually look at the cash in hand, C$5 million is actually 75% US or under $4 million US.

So, no matter how many times you're told, the open secret is a major share dilution up ahead. As they burn thru the 4th quarter, my guess is that this will occur by Christmas. With the economic situation deteriorating, the terms will be much worse than earlier this year.
(By the way, on that last dilution, does anyone but me recall Roger stating that he would never do the share offering below $0.50? That didn't seem to work out just is like most of his promises). 

Merry Christmas! 
 

Bullboard Posts